A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activating FLT3 mutations

Fiedler, Walter; Kayser, Sabine; Kebenko, Maxim; Janning, Melanie; Krauter, Juergen; Schittenhelm, Marcus; Goetze, Katharina; Weber, Daniela; Goehring, Gudrun; Teleanu, Veronica; Thol, Felicitas; Heuser, Michael; Doehner, Konstanze; Ganser, Arnold; Doehner, Hartmut; Schlenk, Richard F.

dc.contributor.author	Schittenhelm, Marcus Matthias
dc.date.accessioned	2015-10-07T13:12:54Z
dc.date.available	2015-10-07T13:12:54Z
dc.date.issued	2015
dc.identifier.issn	0007-1048
dc.identifier.uri	http://hdl.handle.net/10900/65387
dc.language.iso	en	en
dc.publisher	Wiley - Blackwell	de_DE
dc.relation.uri	http://dx.doi.org/10.1111/bjh.13353
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activating FLT3 mutations	de_DE
dc.type	Article	de_DE
utue.quellen.id	20150901145020_00606
utue.publikation.seiten	694-700	de_DE
utue.personen.roh	Fiedler, Walter
utue.personen.roh	Kayser, Sabine
utue.personen.roh	Kebenko, Maxim
utue.personen.roh	Janning, Melanie
utue.personen.roh	Krauter, Juergen
utue.personen.roh	Schittenhelm, Marcus
utue.personen.roh	Goetze, Katharina
utue.personen.roh	Weber, Daniela
utue.personen.roh	Goehring, Gudrun
utue.personen.roh	Teleanu, Veronica
utue.personen.roh	Thol, Felicitas
utue.personen.roh	Heuser, Michael
utue.personen.roh	Doehner, Konstanze
utue.personen.roh	Ganser, Arnold
utue.personen.roh	Doehner, Hartmut
utue.personen.roh	Schlenk, Richard F.
dcterms.isPartOf.ZSTitelID	British Journal of Haematology	de_DE
dcterms.isPartOf.ZS-Issue	5	de_DE
dcterms.isPartOf.ZS-Volume	169	de_DE
utue.fakultaet	04 Medizinische Fakultät